BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 189007)

  • 1. The effect of tolbutamide on contractility and cyclic adenosine 3':5'-monophosphate concentration in the intact beating rat heart.
    Brown JD; Brown ME
    J Pharmacol Exp Ther; 1977 Jan; 200(1):166-73. PubMed ID: 189007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of verapamil on myocardial contractility, cardiac adenosine 3,'5'-monophosphate and heart phosphorylase.
    Shanfeld J; Hess ME; Levine NR
    J Pharmacol Exp Ther; 1975 May; 193(2):317-26. PubMed ID: 167148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiac pharmacology of tolbutamide.
    Curtis GP; Setchfield J; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jul; 194(1):264-73. PubMed ID: 1151754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epinephrine, cyclic AMP, calcium, and myocardial contractility.
    Williamson JR; Schaffer S
    Recent Adv Stud Cardiac Struct Metab; 1976; 9():205-23. PubMed ID: 176696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions and interactions of theophylline and imidazole on cardiac contractility, phosphorylase activation and cyclic AMP.
    Verma SC; McNeill JH
    Arch Int Pharmacodyn Ther; 1976 May; 221(1):4-8. PubMed ID: 183614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and inotropic effects of verapamil in perfused rat heart.
    Hess ME; Shanfeld J; Levine NR
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():81-8. PubMed ID: 174169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness to glucagon in fetal hearts. Species variability and apparent disparities between changes in beating, adenylate cyclase activation, and cyclic AMP concentration.
    Wildenthal K; Allen DO; Karlsson J; Wakeland JR; Clark CM
    J Clin Invest; 1976 Mar; 57(3):551-8. PubMed ID: 175087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
    MacDonell KL; Diamond J
    Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diazepam potentiates the effects of endogenous catecholamines on contractility and cyclic AMP levels in rat ventricular myocardium.
    Marín J; Hernández J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):260-8. PubMed ID: 11919649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of glucagon on rat cardiac cyclic AMP, phosphorylase a and force of contraction.
    Brunt ME; McNeill JH
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):42-52. PubMed ID: 210728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart.
    Lubbe WF; Podzuweit T; Daries PS; Opie LH
    J Clin Invest; 1978 May; 61(5):1260-9. PubMed ID: 207734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of trapidil on the heart contractility: relationship to the cyclic nucleotide metabolism.
    Bartel S; Reese D; Krause EG
    Biomed Biochim Acta; 1987; 46(8-9):S472-6. PubMed ID: 2829868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of myocardial cyclic AMP and vulnerability to fibrillation in the rat heart.
    Lubbe WF; Nguyen T; West EJ
    Fed Proc; 1983 May; 42(8):2460-4. PubMed ID: 6301887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamines, glucagon, energy metabolism and protein degradation in rat heart.
    Chua BH; Siehl DL; Morgan HE
    Cardioscience; 1990 Mar; 1(1):19-28. PubMed ID: 1966372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic and electrophysiological effects of tolbutamide in normal subjects.
    Greco AV; Rebuzzi AG; Santarelli P; Biasucci L; Zecchi P
    G Ital Cardiol; 1982; 12(9):685-7. PubMed ID: 7169169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norepinephrine- and isoproterenol- induced changes in cardiac contractility and cyclic adenosine 3':5' -monophosphate levels during early development of the embryonic chick.
    Polson JB; Goldberg ND; Shideman FE
    J Pharmacol Exp Ther; 1977 Mar; 200(3):630-7. PubMed ID: 191591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dobutamine on rat cardiac cyclic AMP, phosphorylase a and force of contraction.
    McNeill JH
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):597-600. PubMed ID: 209506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H2-histaminergic activity of clonidine in the guinea pig heart.
    Verma SC; McNeill JH
    J Cyclic Nucleotide Res; 1977 Apr; 3(2):95-106. PubMed ID: 195988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rubidium on contractility and sodium pump activity in guinea-pig ventricle.
    Knight RG; Nosek TM
    J Pharmacol Exp Ther; 1981 Nov; 219(2):573-9. PubMed ID: 6270315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.